SCHEMBL24813347

SCHEMBL24813347

c1ccc(-c2ccc(-c3cccc(-c4ccc(-c5ccc6c(-c7ccc8ccccc8c7)c7ccccc7c(-c7ccc8ccccc8c7)c6c5)cc4)n3)cc2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 3/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
PKM P14618 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
KLF5 Q13887 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SIRT2 Q8IXJ6 2/20 0.41
DHODH Q02127 1/20 0.40
CCR1 P32246 2/20 0.40
CCR5 P51681 2/20 0.40
CCR8 P51685 2/20 0.40
ALPL P05186 1/20 0.40
HSP90AA1 P07900 1/20 0.40
ALPI P09923 1/20 0.40
ALPG P10696 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10353273 0.96 KDM4E (0.46) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL24812258 0.96 SMN1; SMN2 (0.46) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL15977771 0.96 SMN1; SMN2 (0.48) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL15977931 0.93 SMN1; SMN2 (0.48) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL10030057 0.92 SMN1; SMN2 (0.49) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL15977878 0.91 SMN1; SMN2 (0.41) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL15977681 0.91 SMN1; SMN2 (0.46) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL18431875 0.91 SMN1; SMN2 (0.44) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL10030067 0.91 SIRT2 (0.47) SMN1; SMN2KDM4ELMNATP53MAPT
SCHEMBL13658731 0.91 SMN1; SMN2 (0.49) SMN1; SMN2KDM4ELMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 SMN1; SMN2 3245/4885KDM4E 3416/4885LMNA 1370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.